Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Working to Increase Vaccination for Human Papillomavirus: A Survey of Wisconsin Stakeholders, 2015

ORIGINAL RESEARCH — Volume 14 — September 28, 2017

PEER REVIEWED

Figures 1a–d.
Percentage of Wisconsin stakeholder organizations (N = 117) reporting activities to increase human papillomavirus vaccination in Wisconsin, 2013–2015. Figure 1a shows stakeholder organizations with activities focused on adolescents and parents, 1b shows stakeholder organizations with activities focused on clinical and health professionals, 1c shows stakeholder organizations with activities focused on communities and health systems, and 1d shows stakeholder organizations with activities focused on advocacy and public policy. The rates of advocating for public policy change and advocating for increased public funding increased over time (P < .05).

Stakeholder Target Audience 2013 2014 2015
Activity Rate, %
1a. Adolescents and parents
Printed educational materials 46.2 58.1 69.2
One-on-one consultations 41.0 48.7 54.7
Reminders of vaccination 26.5 38.5 47.9
Referrals to vaccination services 32.5 44.4 46.2
1b. Clinical and health professionals
Printed educational materials 28.2 41.9 53.0
Professional education 19.7 40.2 47.0
Protocols to track and report vaccination rates 13.7 20.5 35.0
Website focused on health professionals 4.3 5.1 11.1
1c. Communities and health systems
Community events or health fairs 6.0 22.2 21.4
Media campaigns to raise awareness 6.8 25.6 39.3
Community committees or work groups 10.3 16.2 24.8
Funding and promotion 12.0 17.9 23.1
1d. Advocacy and public policy
Advocate public policy change 5.1 7.7 14.5
Advocate for increasing public funding for vaccination 3.4 5.1 11.1
Advocate for increasing public funding for research 2.6 2.6 4.3

Return to Article

 

 

Figures 2a–d.
Percentage of Wisconsin stakeholder organizations (N = 117) reporting barriers to human papillomavirus (HPV) vaccination, from 2013 through 2015. Figure 2a shows percentage of stakeholder organizations reporting barriers related to adolescents and parents (n = 75), 2b shows the percentage of stakeholder organizations reporting barriers related to clinical and health professionals (n = 54), 2c shows the percentage of stakeholder organizations reporting barriers related to communities and health systems (n = 43), and 2d shows the percentage of stakeholder organizations reporting barriers related to advocacy and public policy (n = 10). Abbreviation: STI, sexually transmitted infection.

Category %
2a. Adolescents and parents, n = 75
Lack of education 86.6
Logistical barriers 74.7
Deferred vaccination 71.7
Belief that adolescent is not at risk 71.6
Belief that child is too young 68.5
2b. Clinical and health professionals, n = 54
Ensure the completion of 3 doses 63.0
Concern that parents will decline 57.7
Reluctance to discuss sexuality or STIs 45.3
Concern about time to discuss the vaccine 41.5
HPV vaccination not required for school attendance 37.1
2c. Communities and health systems, n = 43
Lack of education 44.1
Ensure the completion of 3 doses 41.9
Belief that child is too young 41.8
Lack of information 39.5
Reluctance to discuss sexuality or STIs 38.7
2d. Advocacy and public policy, n = 10
Lack of provider recommendation 70.0
Concerns about vaccine safety 60.0
Reluctance to discuss sexuality or STIs 60.0
Lack of information 50.0
Lack of education 50.0

Return to Article

Top

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions.

TOP